Core Viewpoint - Compass Pathways plc has announced the pricing of its public offering, aiming to enhance patient access to innovative treatments [1] Group 1: Public Offering Details - The company is offering 17,500,000 American Depositary Shares (ADSs) at a price of $8.00 per ADS, with each ADS representing one ordinary share [1] - Additionally, the company is providing pre-funded warrants to certain institutional investors to purchase up to 1,250,000 ADSs at a price of $7.9999 [1]